BETRFOTCPharmaceutical PreparationsFiscal year ends January 31
BetterLife Pharma Inc.
Financials through fiscal 2026, year ended Jan 31, 2026Last filing: 20-F on Jun 1, 2026
$0.15−0.01 (-3.71%)
Close on Oct 19, 2026
- Market cap
- $22.36M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$0.1143 (+293.1%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jan 31, 2026
Valuation
- Market cap
- $22.36M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Diluted shares
- 146M
Fifteen years at a glance
Fiscal years 2012 to 2026, USD
Operating income
–
Net income
–
EPS, diluted
–
Reported period